Literature DB >> 10968905

Use of the dilute Russell viper venom time (dRVVT): its importance and pitfalls.

D A Triplett1.   

Abstract

Antiphospholipid antibodies (APA) are now recognized as the most common cause of acquired thrombophilia. These antibodies may lead to thrombosis in both arterial and venous sites. Lupus anticoagulants (LA) are the most significant risk factor among the various APAs. The detection of LAs remains challenging to most laboratories. Multiple screening tests are recommended (e.g. APTT, dilute PT and dRVVT). The dRVVT is one of the most important screening procedures. In many instances, commercially available dRVVT systems include a screening reagent with low PL concentration and a confirmatory product with high PL concentration. There are a number of commercially available dRVVT test systems. These reagents vary in phospholipid origin and concentration as well as source of Russell viper venom (RVV). It is imperative for laboratories to be well informed regarding reagent composition and laboratory performance. Copyright 2000 Academic Press.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10968905     DOI: 10.1006/jaut.2000.0414

Source DB:  PubMed          Journal:  J Autoimmun        ISSN: 0896-8411            Impact factor:   7.094


  7 in total

1.  Prediction of adverse pregnancy outcome by the presence of lupus anticoagulant, but not anticardiolipin antibody, in patients with antiphospholipid antibodies.

Authors:  Michael D Lockshin; Mimi Kim; Carl A Laskin; Marta Guerra; D Ware Branch; Joan Merrill; Michelle Petri; T Flint Porter; Lisa Sammaritano; Mary D Stephenson; Jill Buyon; Jane E Salmon
Journal:  Arthritis Rheum       Date:  2012-07

2.  Effects of thromboprophylactic doses of apixaban and rivaroxaban on coagulation and thrombin generation in association with total hip replacement.

Authors:  Tuukka A Helin; Lauri Virtanen; Mikko Manninen; Jarkko Leskinen; Juhana Leppilahti; Lotta Joutsi-Korhonen; Riitta Lassila
Journal:  J Thromb Thrombolysis       Date:  2017-05       Impact factor: 2.300

3.  Clinical usefulness of the dilute Russell viper venom time test for patients taking warfarin.

Authors:  Kazunori Kanouchi; Hiroto Narimatsu; Okio Ohnuma; Keita Morikane; Akira Fukao
Journal:  Int J Hematol       Date:  2017-04-07       Impact factor: 2.490

4.  Venom Concentrations and Clotting Factor Levels in a Prospective Cohort of Russell's Viper Bites with Coagulopathy.

Authors:  Geoffrey K Isbister; Kalana Maduwage; Fiona E Scorgie; Seyed Shahmy; Fahim Mohamed; Chandana Abeysinghe; Harendra Karunathilake; Margaret A O'Leary; Christeine A Gnanathasan; Lisa F Lincz
Journal:  PLoS Negl Trop Dis       Date:  2015-08-21

Review 5.  Endothelium, Platelets, and Coagulation Factors as the Three Vital Components for Diagnosing Bleeding Disorders: A Simplified Perspective with Clinical Relevance.

Authors:  Abhinav Bhattarai; Sangam Shah; Sara Bagherieh; Omid Mirmosayyeb; Sangharsha Thapa; Sandip Paudel; Pawan Gyawali; Pitambar Khanal
Journal:  Int J Clin Pract       Date:  2022-08-27       Impact factor: 3.149

6.  Combining Taipan snake venom time/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients.

Authors:  Gary W Moore
Journal:  Thromb J       Date:  2007-09-06

7.  The Procoagulant Snake Venom Serine Protease Potentially Having a Dual, Blood Coagulation Factor V and X-Activating Activity.

Authors:  Zorica Latinović; Adrijana Leonardi; Cho Yeow Koh; R Manjunatha Kini; Alenka Trampuš Bakija; Jože Pungerčar; Igor Križaj
Journal:  Toxins (Basel)       Date:  2020-05-29       Impact factor: 4.546

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.